Tirzepatide: how much can you lose in a month, realistically?

Month one: you're adjusting, not yet cruising

Picture this: your first pen has arrived, you've taken your first dose, and you're already wondering whether the scales will shift this week. The honest answer is: probably a little, but not dramatically, and that's by design. Tirzepatide begins at 2.5mg, a starting dose whose main job is helping your system settle in rather than delivering maximum appetite suppression from day one. Prescribers move patients through the dose schedule gradually, typically in four-week steps, which means the first month is largely an acclimatisation period.

Nausea, some reduced appetite, and mild digestive changes are common early on. The appetite effect does begin, and some weight loss follows, realistic expectations for month one sit in the 1–2% body-weight range for many people, which for a 90kg adult is roughly 0.9–1.8kg. Some people lose more; some less. Individual response varies based on starting weight, diet, activity, and biology. The full picture of what tirzepatide weight loss looks like across the treatment course is a better framework than fixating on week four.

The reason this matters for cost: month one is the most expensive moment relative to the results you'll see. If a provider's pricing makes the first month feel painfully steep with no support structure around it, that's worth knowing before you start.

Months two to six: where the numbers start to move more clearly

By months two and three, most people are on a higher dose, and that's when the appetite-reducing effect of tirzepatide tends to become more pronounced. Average monthly losses of 2–4% of body weight become more achievable for many patients during this phase, though the pace naturally slows as weight falls. If you want a concrete sense of how much you can lose on Mounjaro in 3 months and what the research says about that early window, it's a useful reference point before setting your expectations.

The wider SURMOUNT programme (across the SURPASS diabetes trials and the SURMOUNT weight-management trials combined, involving over 10,000 participants) consistently showed that results build over time, not in a single month. At 72 weeks, tirzepatide 15mg produced average reductions of around 20–21% of body weight in people without diabetes. If you're curious about how much you can lose on Mounjaro over the full course of treatment, the numbers across the trial programme give a clearer picture than any single monthly snapshot. One practical thing worth doing before you start: note your current weight in your phone alongside today's date. Checking it at the same time each week (same morning, same conditions) gives you a reliable trend line rather than noise from daily fluctuations. One minute, once a week, and you'll avoid the trap of reading too much into a single reading.

What private treatment costs, and what the price should actually cover

UK private tirzepatide pricing has shifted significantly since September 2025, when Eli Lilly raised the list price of Mounjaro. Reported market rates now range roughly £149–£375 per month depending on dose and provider. That's a wide spread, and it isn't entirely explained by dose differences.

What the lower-end headline prices often don't include: an upfront consultation fee charged separately, a prescription processing charge, delivery costs added at checkout, or any form of clinical aftercare between orders. When you add those up, the apparent saving narrows or disappears. What tirzepatide costs in the UK depends as much on what's wrapped around the medicine as the pen price itself.

At nume, we're not trying to be the cheapest option, that's a deliberate choice. One price covers the consultation, the prescription, the treatment, free next-working-day DPD delivery, and seven-day aftercare. No hidden charges appear at checkout. Every repeat order goes back to a real prescriber for review; there's no subscription that ships automatically. You can see what's currently available by visiting our treatment page. For more on how Mounjaro pricing is structured in the UK, the Mounjaro price page covers the full context.

Why 'cheapest' is the wrong test for a prescription medicine

A significant escalation in enforcement through 2024 and 2025 (including raids on illicit manufacturing operations and the seizure of approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million) reflects just how active the counterfeit market for GLP-1 medicines has become. The MHRA's Yellow Card scheme accepts reports of suspect sellers, and the regulator has been clear: products sold without clinical assessment through unverified online sources represent a serious patient safety risk.

For a prescription medicine that works gradually over months, the quality of the clinical oversight sitting around it matters as much as the medicine itself. Dose increases, side effect management, and decisions about continuing or adjusting treatment all require a prescriber who actually knows your case. A small saving on the pen price is not worth a prescriber who rubber-stamps every request without review.

Any online pharmacy operating legally in the UK should be verifiable on the GPhC register. Checking takes about thirty seconds. nume's pharmacy registration is 9012878. If a provider isn't there, that's the answer you need. For a broader look at what tirzepatide treatment involves before committing to any service, the Mounjaro overview is a good starting point. And if you'd like to know whether you meet the clinical criteria for treatment, checking your eligibility is free and takes a few minutes.